Ma, J <br/><br/>
Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer.  [electronic resource] 

 -  Cancer research  Mar 1997 
 - 1098-102 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alcohol Drinking--adverse effects<br/>Aspirin--therapeutic use<br/>Case-Control Studies<br/>Cocarcinogenesis<br/>Colorectal Neoplasms--enzymology<br/>DNA Methylation<br/>DNA Replication<br/>Diet--adverse effects<br/>Double-Blind Method<br/>Folic Acid--blood<br/>Folic Acid Deficiency--complications<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Male<br/>Methylenetetrahydrofolate Reductase (NADPH2)<br/>Middle Aged<br/>Odds Ratio<br/>Oxidoreductases Acting on CH-NH Group Donors--genetics<br/>Point Mutation<br/>Polymorphism, Genetic<br/>Prospective Studies<br/>Risk<br/>Tetrahydrofolates--metabolism<br/>United States--epidemiology<br/>beta Carotene--therapeutic use